<DOC>
	<DOC>NCT01959074</DOC>
	<brief_summary>This study is To confirm the efficacy of Naftopidil for reducing discomfort of ureteral stent after urinary stone surgery.</brief_summary>
	<brief_title>The Effect of Naftopidil for the Double-J Stent Discomfort</brief_title>
	<detailed_description>1. Enrollment 1. patients underwent Double-J ureteral stent indwelling after urological surgery during less than 15 days 2. patients aged more than 20 years 2. Randomization 1. naftopidil 75 mg qd or placebo until Double-J stent removal 2. Standard treatment with pain-killers on demand were also applied.(aceclofenac) 3. Follow-up to the day of Double-J stent removal (Evaluation should be done at stent removal)</detailed_description>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<criteria>Patients to be undergone doubleJ stent indwelling &gt;= 20 years undergoing unilateral retrograde double J (DJ) stent placement planned for 515 days indwelling after percutaneous nephrolithotomy, open or laparoscopic ureterolithotomy presence of ureteral stone renal insufficiency (serum Cr &gt; 1.4) febrile urinary tract infection (fever &gt; 38.0Â°C, evidence of urinary infection ) pregnancy or breast feeding solitary kidney hypersensitivity to Naftopidil current use of any alpha blocker, calcium channel blocker, corticosteroid moderate or sever cardiovascular or cerebrovascular disease hepatic dysfunction prior history of pelvic surgery or irradiation prior history of transurethral resection of bladder tumor or prostate surgery significant active medical illness which in the opinion of the investigator would preclude protocol treatment genetic disorder such ad galactose intolerance, lapp lactase deficiency, glucosegalactose malabsorption</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>